Medical Oncology Analysis

Harris JR , Lippman M , Morrow M , Osborne CK. Diseases of the Breast. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.

Nabholtz JM , Tonkin K , Aapro MS , Buzdar AU. Breast Cancer Management. London, England: Martin Dunitz; 2000.

Thor AD , Berry DA , Budman D , et al. ErbB-2, p 53 and efficacy of adjuvant therapy in lymph node-positive breast cancer. J Natl Cancer Inst. 1998;90:1346.

Henderson IC . Endocrine Therapy, Chemotherapy, or Both As Adjuvant Systemic Treatment of Patients With Early Breast Cancer. Alexandria, Va: American Society of Clinical Oncology Educational Book; 2001.

Goss PE , Strasser K. Aromatase inhibitor in treatment and prevention of breast cancer. J Clin Oncol. 2001;19:881-894.

Hortobagyi GN , Theriault RL , Lipton A , et al. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia breast cancer study group. J Clin Oncol. 1998;16:2038-2044.

Slamon DJ , Leyland-Jones B , ShakS , et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344(11):783-792.

Perez EA , Vogel CL , Irwin DH , et al. Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J Clin Oncol. 2001;19:4216-4223